Millennium Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL)

Millennium Management LLC bought a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 503,695 shares of the company's stock, valued at approximately $13,036,000. Millennium Management LLC owned about 1.41% of CeriBell at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. FMR LLC purchased a new position in shares of CeriBell during the fourth quarter worth $128,120,000. ABG WTT Global Life Science Capital Partners GP Ltd purchased a new position in shares of CeriBell during the fourth quarter worth $28,160,000. RA Capital Management L.P. acquired a new stake in CeriBell during the fourth quarter valued at $21,340,000. Vanguard Group Inc. acquired a new stake in CeriBell during the fourth quarter valued at $18,015,000. Finally, Board of Trustees of The Leland Stanford Junior University acquired a new stake in CeriBell during the fourth quarter valued at $16,143,000.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Canaccord Genuity Group restated a "buy" rating and set a $33.00 price target on shares of CeriBell in a research report on Wednesday, February 26th. LADENBURG THALM/SH SH assumed coverage on shares of CeriBell in a research report on Friday, April 4th. They set a "buy" rating and a $32.00 price target on the stock. Seven research analysts have rated the stock with a buy rating, According to MarketBeat, CeriBell has an average rating of "Buy" and a consensus price target of $32.50.

Insider Buying and Selling

In related news, CEO Xingjuan Chao sold 25,000 shares of the business's stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $16.96, for a total transaction of $424,000.00. Following the transaction, the chief executive officer now directly owns 727,151 shares in the company, valued at approximately $12,332,480.96. The trade was a 3.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders have sold 49,700 shares of company stock worth $796,434. 20.10% of the stock is owned by insiders.

CeriBell Stock Up 0.3%

Shares of NASDAQ CBLL traded up $0.06 during trading on Thursday, hitting $17.25. The company had a trading volume of 52,704 shares, compared to its average volume of 267,273. The stock has a fifty day simple moving average of $16.94 and a two-hundred day simple moving average of $21.92. CeriBell has a fifty-two week low of $10.01 and a fifty-two week high of $32.75.

CeriBell (NASDAQ:CBLL - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.07. The company had revenue of $20.49 million during the quarter, compared to analyst estimates of $19.30 million. Equities analysts predict that CeriBell will post -2.46 EPS for the current fiscal year.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.